Literature DB >> 3108589

Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells.

G Hensel, D N Männel, K Pfizenmaier, M Krönke.   

Abstract

We have employed a human promyelocytic leukemic cell line, HL-60, to investigate the conditions that regulate TNF-alpha gene expression in vitro. Using a cloned TNF-alpha specific cDNA probe, we show by Northern blot analysis that TNF-alpha mRNA rapidly accumulates in HL-60 cells following treatment with phorbol myristate acetate (PMA). TNF-alpha mRNA levels peak at 1-2 hours and then decline to base-line levels within 8 hours. TNF-alpha protein levels as detected in the supernatants of PMA-stimulated HL-60 cells peak at 2 hours and decline within 24 hours. Cytokines of recombinant source like interferon-alpha and -gamma, and, more intruigingly, TNF-beta as well as TNF-alpha itself are also able to induce transient TNF-alpha mRNA expression in HL-60 cells. In the presence of a protein kinase inhibitor, neither PMA nor any of the cytokines used are able to induce TNF-alpha mRNA accumulation, indicating that protein kinases may be crucially involved in signal transduction leading to activation of the TNF-alpha gene. The data presented provide new insights into the control of TNF-alpha gene expression suggesting regulatory functions of T- and B-cell derived lymphokines as well as a TNF-alpha-mediated positive feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108589

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  14 in total

1.  Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.

Authors:  B Soliven; S Szuchet; D J Nelson
Journal:  J Membr Biol       Date:  1991-11       Impact factor: 1.843

Review 2.  Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition.

Authors:  K Pfizenmaier; M Krönke; P Scheurich; G A Nagel
Journal:  Blut       Date:  1987-07

3.  Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins.

Authors:  M Kohno; N Nishizawa; M Tsujimoto; H Nomoto
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

4.  Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2.

Authors:  P L Hsu; S M Hsu
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

5.  Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Authors:  S Beissert; M Bergholz; I Waase; G Lepsien; A Schauer; K Pfizenmaier; M Krönke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: role for NF-kappa B.

Authors:  N L Paul; M J Lenardo; K D Novak; T Sarr; W L Tang; N H Ruddle
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Effect of water-soluble PM10 on the production of TNF-α by human monocytes and induction of apoptosis in A549 human lung epithelial cells.

Authors:  Mohammad Ghasemi Dehcheshmeh; Ata Ghadiri; Mohammad Rashno; Mohammad Ali Assarehzadegan; Ali Khodadadi; Gholamreza Goudarzi
Journal:  J Environ Health Sci Eng       Date:  2021-01-07

8.  Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines.

Authors:  A E Goldfeld; J L Strominger; C Doyle
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C.

Authors:  S Schütze; D Berkovic; O Tomsing; C Unger; M Krönke
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.